Journal: Journal of Immunology Research
Article Title: Glucans: A Therapeutic Alternative for Sepsis Treatment
doi: 10.1155/2024/6876247
Figure Lengend Snippet: Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
Article Snippet: Microorganism: yeast, S. cerevisiae , 1 → 3−1 → 6- β -D-Glucan (Mustafa Nevzat Company, Turkey. S. cerevisiae ) , In vivo ( rats: albino wistar ) , 50 mg (kg) , GIG , Once a day for 10 days , ↓ Zinc and copper levels of the liver, lung, kidney, heart, and diaphragm. ↓ Tissue damage , [ ] .
Techniques: Formulation, Activity Assay, Saline, In Vivo, Injection, Expressing, Translocation Assay, Mouse Assay, Activation Assay, In Vitro, Clinical Proteomics